- Home
- Johnson & Johnson MedTech
Johnson & Johnson MedTech
Johnson & Johnson named to Fortune‘s 2023 America’s Most Innovative Companies list
The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson’s mission to improve health for people across the globe for over a century.
Johnson & Johnson named a 2023 Fortune World’s Most Admired Company and ranked #1 on the Pharmaceutical Industry list.
A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.
What you need to know about Johnson & Johnson’s 2022 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Meet 7 people who inspired us in 2022
Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.
4 things we now know about hip replacement surgery
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
What happens when antibiotics stop working?
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
What you need to know about Johnson & Johnson’s 2022 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
What you need to know about Johnson & Johnson’s 2022 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
“Why I decided to undergo facial feminization surgery”
For International Transgender Day of Visibility, Lynn Discenza shares her transition journey and how gender-affirmation surgery helped her reclaim her confidence and be who she’s always wanted to be. Plus, learn how Johnson & Johnson MedTech is working to help ensure more people have access to the life-changing procedure.
What you need to know about Johnson & Johnson’s 2022 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.